I don't see why you repeatedly accuse MBA people or the pharma scientists of not "caring" then proceed to explain multiple reasons why it's infeasible as a private business or even an academic or public organization.
There's plenty of serious health issues constantly competing for a small pool of smart medical peoples attention and with a limited capital.
Genetic tailoring still currently involves a high amount of specialist attention per individual and there is plenty of research and money going into it. I've heard multiple doctors tell me it's the future of medicine.
Whether it could use more attention and capital is certainly a good question.
There's plenty of serious health issues constantly competing for a small pool of smart medical peoples attention and with a limited capital.
Genetic tailoring still currently involves a high amount of specialist attention per individual and there is plenty of research and money going into it. I've heard multiple doctors tell me it's the future of medicine.
Whether it could use more attention and capital is certainly a good question.